Date: 2026-02-28Category: Press ReleaseState: Union GovernmentCountry: India
Indian Pharmacopoeia Commission (IPC) and Andhra Pradesh MedTech Zone (AMTZ) Organise National Meet on Strengthening Pharmacovigilance and Materiovigilance in India at Visakhapatnam
**Executive Summary**
The Indian Pharmacopoeia Commission (IPC) and Andhra Pradesh MedTech Zone (AMTZ) organized a National Meet in Visakhapatnam on February 27-28, 2026, to strengthen Pharmacovigilance and Materiovigilance in India. The meet included the first-ever annual meeting of regional centers participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI). The ADR PvPI 2.0 Mobile Application was launched during the meet to enhance real-time adverse drug reaction reporting and patient safety.
**Key Points / Main Content**
* **Purpose and Objectives:**
* Strengthen India's drug and medical device safety systems.
* Enhance coordination among regulators, healthcare institutions, ADR Monitoring Centres (AMCs), and Medical Device Monitoring Centres (MDMCs).
* Transition from awareness-driven reporting to a performance-oriented pharmacovigilance framework.
* **Key Activities and Discussions:**
* Review progress under PvPI and MvPI.
* Deliberate on challenges including underreporting of adverse drug reactions and documentation gaps.
* Discuss the need for strengthened medical device safety oversight.
* Enhance the performance of AMCs and MDMCs and promote a culture of systematic reporting.
* Working groups examined strategies to address underreporting, develop standardized frameworks for documentation and analysis of preventable adverse events, and expand outreach.
* **Outcomes and Recommendations:**
* Emphasized capacity building and standardization of reporting practices.
* Improved inter-institutional coordination.
* Integration of technology-enabled monitoring mechanisms to strengthen patient safety.
* Reaffirmation of IPC's commitment to strengthen India's pharmacovigilance and materiovigilance ecosystem.
* **Technological Advancement:**
* Launch of the ADR PvPI 2.0 Mobile Application to facilitate ease of reporting and strengthen data capture.
**Impact Analysis**
**Regulators, Healthcare Institutions, AMCs, and MDMCs Impact**
* **Impact:** Improved coordination and standardized practices in pharmacovigilance and materiovigilance.
* **Action Required:** Implement the recommendations emerging from the deliberations, including capacity building, standardized reporting practices, and improved inter-institutional coordination.
**Patients Impact**
* **Impact:** Enhanced patient safety through improved monitoring mechanisms and real-time adverse drug reaction reporting.
* **Action Required:** Utilize the ADR PvPI 2.0 Mobile Application to report adverse drug reactions and contribute to improved patient safety.
Key Entities Referenced
Indian Pharmacopoeia Commission (IPC): Organized the National Meet on Strengthening Pharmacovigilance and Materiovigilance.
Pharmacovigilance Programme of India (PvPI): A program aimed at strengthening India's drug safety systems.
Materiovigilance Programme of India (MvPI): A program aimed at strengthening India's medical device safety systems.
Andhra Pradesh MedTech Zone (AMTZ): Co-organized the National Meet with IPC and hosted it in Visakhapatnam.
Ministry of Health and Family Welfare
Indian Pharmacopoeia Commission (IPC) and
Andhra Pradesh MedTech Zone (AMTZ) Organise
National Meet on Strengthening
Pharmacovigilance and Materiovigilance in India
at Visakhapatnam
First-Ever National Annual Meet of PvPI and MvPI Regional
Centres to Strengthen India’s Drug and Medical Device
Safety Framework and Institutional Coordination
ADR PvPI 2.0 Mobile Application Launched during the Meet
to Enhance Real-Time Adverse Drug Reaction Reporting and
Patient Safety Across India
From Awareness to Action: National Meet Drives
Coordinated, Technology-Enabled Transformation of Drug
and Medical Device Safety and Patient Protection in India
Posted On: 28 FEB 2026 4:39PM by PIB Delhi
The Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of
India, in collaboration with the Andhra Pradesh MedTech Zone (AMTZ) organised a two-day National
Meet on Strengthening Pharmacovigilance and Materiovigilance in India on 27-28 February 2026 at
Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. In a first-time ever national meet, the 1st
Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI)
and the Materiovigilance Programme of India (MvPI) was organised to strengthen India’s drug and
medical device safety systems and enhance coordination among regulators, healthcare institutions, ADR
Monitoring Centres (AMCs), and Medical Device Monitoring Centres (MDMCs). Senior officials from
regulatory authorities, leading medical institutions, and representatives from the WHO Country Office for
India participated in the deliberations.The inaugural session was presided over by Dr V Kalaiselvan, Secretary-cum-Scientific Director, IPC,
who underscored the need to transition from awareness-driven reporting to a performance-oriented
pharmacovigilance framework with measurable outcomes. Senior leadership from leading AIIMS
institutions, including Prof. Y K Gupta, Prof. Ashok Puranik, along with Dr Jitendra Sharma, Managing
Director and Founder CEO, AMTZ, and Dr Kavita Kachroo, CEO, Kalam Institute of Health Technology,
participated in the inaugural session and highlighted the importance of institutional collaboration in
strengthening pharmacovigilance and materiovigilance systems across the country.
During the inaugural session, the ADR PvPI 2.0 Mobile Application was launched to facilitate ease of
reporting, strengthen real-time data capture, and improve stakeholder engagement in adverse drug reaction
monitoring across the country.Technical sessions were conducted to review progress under PvPI and MvPI and to deliberate on key
challenges including underreporting of adverse drug reactions, documentation gaps, and the need for
strengthening medical device safety oversight. Discussions also focused on enhancing the performance of
AMCs and MDMCs and promoting a culture of systematic reporting in healthcare institutions.
The second day of the meet was devoted to structured working group deliberations under the theme
“Empowering India’s Pharmacovigilance and Materiovigilance: From Awareness to Action.” Along with
the technical sessions, the working groups examined strategies to address underreporting, develop
standardised frameworks for documentation and analysis of preventable adverse events, and expand
pharmacovigilance and materiovigilance outreach beyond district-level healthcare facilities.
The recommendations emerging from the deliberations emphasised capacity building, standardisation of
reporting practices, improved inter-institutional coordination, and integration of technology-enabled
monitoring mechanisms to strengthen patient safety.
The meet concluded with a reaffirmation of IPC’s commitment to further strengthening India’s
pharmacovigilance and materiovigilance ecosystem through coordinated and evidence-based
interventions.****
SR
HFW/IPC and AMTZ Host National Meet to Strengthen India’s Pharmacovigilance & Materiovigilance
Systems /28th February 2026/2
(Release ID: 2233933) Visitor Counter : 414
Read this release in: Urdu , ही , Tamil , Telugu